Pharmaceutical Outsourcing

Published on: 09/17/2015

The Pharmaceutical Outsourcing industry is finally benefitting from an improving drug pipeline (2014 featured the highest number of novel new drug approvals in the past decade). A reported increase in utilization of outsourcing by big pharma, and the proliferation of biologics and medicines for rarer diseases which are disproportionately being developed by venture‐backed or mid‐sized pharmaceutical companies who by design or necessity rely more heavily on outsourced providers.

Key Contacts